SENP1-IN-1 (C007B-419018)

SENP1-IN-1 is a specific deSUMOylation protease 1 (SENP1) inhibitor extracted from patent CN110627860, Compound 29. SENP1-IN-1 is developed for tumor radiosensitivity enhancementIn VitroSENP1-IN-1 may improve the sensitivity of tumor cells to irradiation. SENP1-IN-1 (0.7-20 μM; 72 hours)has cytotoxic for Hella cells with an IC 50 of >20μM. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Cell Cytotoxicity AssayCell Line: Hela cells Concentration: 0.7 μM, 2.2 μM, 6.6 μM, 20 μM Incubation Time: 72 hours Result: IC 50 >20 μMIC50& Target:SENP1. Specification: 10mM in DMSO Molecular Formula: C35H58N2O4 Molecular Weight: 570.85

UPC:

51112702

Condition:

New

Weight:

1.06 Ounces

HazmatClass:

No

Quantity:

1

Unit of Measurement:

EA

WeightUOM:

LB

MPN:

S654999-1ml

CAS:

2416910-69-3

Product Size:

1ml